Flux and Seasonality of Dissolved Organic Matter From the Northern Dvina (Severnaya Dvina) River, Russia

Pan‐Arctic riverine dissolved organic carbon (DOC) fluxes represent a major transfer of carbon from land‐to‐ocean, and past scaling estimates have been predominantly derived from the six major Arctic rivers. However, smaller watersheds are constrained to northern high‐latitude regions and, particularly with respect to the Eurasian Arctic, have received little attention. In this study, we evaluated the concentration of DOC and composition of dissolved organic matter (DOM) via optical parameters, biomarkers (lignin phenols), and ultrahigh resolution mass spectrometry in the Northern Dvina River (a midsized high‐latitude constrained river). Elevated DOC, lignin concentrations, and aromatic DOM indicators were observed throughout the year in comparison to the major Arctic rivers with seasonality exhibiting a clear spring freshet and also some years a secondary pulse in the autumn concurrent with the onset of freezing. Chromophoric DOM absorbance at a350 was strongly correlated to DOC and lignin across the hydrograph; however, the relationships did not fit previous models derived from the six major Arctic rivers. Updated DOC and lignin fluxes were derived for the pan‐Arctic watershed by scaling from the Northern Dvina resulting in increased DOC and lignin fluxes (50 Tg yr−1 and 216 Gg yr−1, respectively) compared to past estimates. This leads to a reduction in the residence time for terrestrial carbon in the Arctic Ocean (0.5 to 1.8 years). These findings suggest that constrained northern high‐latitude rivers are underrepresented in models of fluxes based from the six largest Arctic rivers with important ramifications for the export and fate of terrestrial carbon in the Arctic Ocean

Better reporting of interventions : template for intervention description and replication (TIDieR) checklist and guide

Peer reviewedPublisher PD

The Need for Reporting Metabolic Sampling Interval in Publication: An Example Using Maximal VO2 Values and Running Economy

Background: Knowledge of metabolic outcomes, such as maximal oxygen consumption (VO2) or running economy, has wide-ranging application. Metabolic outcomes are widely reported in literature yet the metabolic sampling interval (example: breath-by-breath, 30-sec average) utilized for collection is rarely ever stated. Purpose: The purposes of the present investigation were to probe the potential discrepancies created when analyzing running economy and VO2max raw metabolic data with four different metabolic sampling intervals. Methods: Five recreationally-active and endurance-trained subjects were included in the present analysis and four metabolic sampling intervals were analyzed: 30-sec average, 20-sec average, 8-breath, and 4-breath. Subjects engaged in 4-min running economy phases at 55 and 65% of their VO2max before entering into a maximal protocol purposed to elicit VO2max in 8-12 minutes. Utilizing the steady state and maximal VO2 data, metabolic sampling intervals were analyzed for their effect on reported VO2 values. Results: For running economy at 55%, there was no differences found (f = 0.207; df = 1.862; p = 0.799) between sampling frequencies when analyzed by repeated measures analysis of variance and corrected with Greenhouse-Geisser for a violation of sphericity. For running economy at 65%, there were also no differences ­found (f = 1.456; df = 3; p = 0.799) between sampling frequencies. For inspection, the relative VO2 values were: 27.2 (±3.1), 27.9 (±4.1), 28.4 (±3.6), and 28.8 (±5.1) for the 30-sec, 20-sec, 8-breath, and 4-breath average, respectively. Maximal VO2 values of 53.0 (±6.6), 55.1 (±7.2), 55.1 (±7.2), and 59.6 (±9.4) for the 30-sec, 20-sec, 8-breath, and 4-breath average, respectively, were found to be significantly different (f = 21.062; df = 1.278; p \u3c 0.001) after adjusting for a violation of sphericity (p \u3c 0.001). Bonferroni analysis indicated differences between the 30-sec average and all other averages and also the 20-sec and 8-breath averages when compared against the 4-breath average. The 4-breath average yielded the highest VO2max value. Coincidentally, the 20-sec and 8-breath averages were identical. Conclusion: In the present investigation of raw metabolic data, sampling interval was found to impact the maximal oxygen consumption (VO2max) values but not running economy values when investigating a small sample of data with four select sampling intervals. The report of maximal VO2 is rather common in the literature and knowing sample interval is vital for between-study comparison, determination of regression-related activities, or for pre-post comparison of data from the same or different labs

Measuring Socioeconomic Inequalities in Relation to Malaria Risk: A Comparison of Metrics in Rural Uganda.

Socioeconomic position (SEP) is an important risk factor for malaria, but there is no consensus on how to measure SEP in malaria studies. We evaluated the relative strength of four indicators of SEP in predicting malaria risk in Nagongera, Uganda. A total of 318 children resident in 100 households were followed for 36 months to measure parasite prevalence routinely every 3 months and malaria incidence by passive case detection. Household SEP was determined using: 1) two wealth indices, 2) income, 3) occupation, and 4) education. Wealth Index I (reference) included only asset ownership variables. Wealth Index II additionally included food security and house construction variables, which may directly affect malaria. In multivariate analysis, only Wealth Index II and income were associated with the human biting rate, only Wealth Indices I and II were associated with parasite prevalence, and only caregiver's education was associated with malaria incidence. This is the first evaluation of metrics beyond wealth and consumption indices for measuring the association between SEP and malaria. The wealth index still predicted malaria risk after excluding variables directly associated with malaria, but the strength of association was lower. In this setting, wealth indices, income, and education were stronger predictors of socioeconomic differences in malaria risk than occupation

TB STIGMA – MEASUREMENT GUIDANCE

TB is the most deadly infectious disease in the world, and stigma continues to play a significant role in worsening the epidemic. Stigma and discrimination not only stop people from seeking care but also make it more difficult for those on treatment to continue, both of which make the disease more difficult to treat in the long-term and mean those infected are more likely to transmit the disease to those around them. TB Stigma – Measurement Guidance is a manual to help generate enough information about stigma issues to design and monitor and evaluate efforts to reduce TB stigma. It can help in planning TB stigma baseline measurements and monitoring trends to capture the outcomes of TB stigma reduction efforts. This manual is designed for health workers, professional or management staff, people who advocate for those with TB, and all who need to understand and respond to TB stigma

Atrial and placental melanoma metastasis: a case report and literature review

Malignant melanoma can metastasize to virtually any organ of the body. The aggressiveness is determined by the primary site, depth of dermal invasion, presence or absence of ulceration, lymphovascular infiltration and regional lymph node involvement. We report a case of a pregnant woman with a previous history of stage 3 melanoma who presented with cardiac metastasis and placental melanoma infiltration. A review of literature on cardiac and placental involvement of melanoma is also provided

A system of ODEs for a Perturbation of a Minimal Mass Soliton

We study soliton solutions to a nonlinear Schrodinger equation with a saturated nonlinearity. Such nonlinearities are known to possess minimal mass soliton solutions. We consider a small perturbation of a minimal mass soliton, and identify a system of ODEs similar to those from Comech and Pelinovsky (2003), which model the behavior of the perturbation for short times. We then provide numerical evidence that under this system of ODEs there are two possible dynamical outcomes, which is in accord with the conclusions of Pelinovsky, Afanasjev, and Kivshar (1996). For initial data which supports a soliton structure, a generic initial perturbation oscillates around the stable family of solitons. For initial data which is expected to disperse, the finite dimensional dynamics follow the unstable portion of the soliton curve.Comment: Minor edit

Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

Background: Limits on the frequency of whole blood donation exist primarily to safeguard donor health. However, there is substantial variation across blood services in the maximum frequency of donations allowed. We compared standard practice in the UK with shorter inter-donation intervals used in other countries. Methods: In this parallel group, pragmatic, randomised trial, we recruited whole blood donors aged 18 years or older from 25 centres across England, UK. By use of a computer-based algorithm, men were randomly assigned (1:1:1) to 12-week (standard) versus 10-week versus 8-week inter-donation intervals, and women were randomly assigned (1:1:1) to 16-week (standard) versus 14-week versus 12-week intervals. Participants were not masked to their allocated intervention group. The primary outcome was the number of donations over 2 years. Secondary outcomes related to safety were quality of life, symptoms potentially related to donation, physical activity, cognitive function, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin. This trial is registered with ISRCTN, number ISRCTN24760606, and is ongoing but no longer recruiting participants. Findings: 45 263 whole blood donors (22 466 men, 22 797 women) were recruited between June 11, 2012, and June 15, 2014. Data were analysed for 45 042 (99·5%) participants. Men were randomly assigned to the 12-week (n=7452) versus 10-week (n=7449) versus 8-week (n=7456) groups; and women to the 16-week (n=7550) versus 14-week (n=7567) versus 12-week (n=7568) groups. In men, compared with the 12-week group, the mean amount of blood collected per donor over 2 years increased by 1·69 units (95% CI 1·59–1·80; approximately 795 mL) in the 8-week group and by 0·79 units (0·69–0·88; approximately 370 mL) in the 10-week group (p<0·0001 for both). In women, compared with the 16-week group, it increased by 0·84 units (95% CI 0·76–0·91; approximately 395 mL) in the 12-week group and by 0·46 units (0·39–0·53; approximately 215 mL) in the 14-week group (p<0·0001 for both). No significant differences were observed in quality of life, physical activity, or cognitive function across randomised groups. However, more frequent donation resulted in more donation-related symptoms (eg, tiredness, breathlessness, feeling faint, dizziness, and restless legs, especially among men [for all listed symptoms]), lower mean haemoglobin and ferritin concentrations, and more deferrals for low haemoglobin (p<0·0001 for each) than those observed in the standard frequency groups. Interpretation: Over 2 years, more frequent donation than is standard practice in the UK collected substantially more blood without having a major effect on donors' quality of life, physical activity, or cognitive function, but resulted in more donation-related symptoms, deferrals, and iron deficiency. Funding: NHS Blood and Transplant, National Institute for Health Research, UK Medical Research Council, and British Heart Foundation

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

BACKGROUND: Vaccination prevents severe morbidity and mortality from COVID-19 in the general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients with antibody deficiency is poorly understood. OBJECTIVES: COVID-19 in patients with antibody deficiency (COV-AD) is a multi-site UK study that aims to determine the immune response to SARS-CoV-2 infection and vaccination in patients with primary or secondary antibody deficiency, a population that suffers from severe and recurrent infection and does not respond well to vaccination. METHODS: Individuals on immunoglobulin replacement therapy or with an IgG less than 4 g/L receiving antibiotic prophylaxis were recruited from April 2021. Serological and cellular responses were determined using ELISA, live-virus neutralisation and interferon gamma release assays. SARS-CoV-2 infection and clearance were determined by PCR from serial nasopharyngeal swabs. RESULTS: A total of 5.6% (n = 320) of the cohort reported prior SARS-CoV-2 infection, but only 0.3% remained PCR positive on study entry. Seropositivity, following two doses of SARS-CoV-2 vaccination, was 54.8% (n = 168) compared with 100% of healthy controls (n = 205). The magnitude of the antibody response and its neutralising capacity were both significantly reduced compared to controls. Participants vaccinated with the Pfizer/BioNTech vaccine were more likely to be seropositive (65.7% vs. 48.0%, p = 0.03) and have higher antibody levels compared with the AstraZeneca vaccine (IgGAM ratio 3.73 vs. 2.39, p = 0.0003). T cell responses post vaccination was demonstrable in 46.2% of participants and were associated with better antibody responses but there was no difference between the two vaccines. Eleven vaccine-breakthrough infections have occurred to date, 10 of them in recipients of the AstraZeneca vaccine. CONCLUSION: SARS-CoV-2 vaccines demonstrate reduced immunogenicity in patients with antibody deficiency with evidence of vaccine breakthrough infection